New drugs under development for COPD-Reference-Cited by-同舟云学术

New drugs under development for COPD

Published:2020-09-29 Issue:4 Volume:25 Page:419-431
ISSN:1472-8214
Container-title:Expert Opinion on Emerging Drugs
language:en
Short-container-title:Expert Opinion on Emerging Drugs

Author:

Lo Bello Federica¹^ORCID,Hansbro Philip M.²³⁴^ORCID,Donovan Chantal²³⁴^ORCID,Coppolino Irene¹^ORCID,Mumby Sharon⁵^ORCID,Adcock Ian M.⁵^ORCID,Caramori Gaetano¹^ORCID

Affiliation:

1. Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e Delle Immagini Morfologiche e Funzionali (BIOMORF), Università di Messina, Messina, Italy

2. Centre for Inflammation, Centenary Institute, Sydney, Australia

3. Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia

4. Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and the University of Newcastle, Newcastle, NSW, Australia

5. Airways Disease Section, National Heart and Lung Institute, Imperial College, London, UK

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728214.2020.1819982

Reference97 articles.

1. Molecular links between COPD and lung cancer: new targets for drug discovery?

2. Novel Pyrrolidine Derivatives of Budesonide as Long Acting Inhaled Corticosteroids for the Treatment of Pulmonary Inflammatory Diseases

3. Selective Nonsteroidal Glucocorticoid Receptor Modulators for the Inhaled Treatment of Pulmonary Diseases

Safety, pharmacokinetics and pharmacodynamics of the selective glucocorticoid receptor modulator AZD7594, following inhalation in healthy Japanese volunteers

5. Pharmacology and Therapeutics of Bronchodilators Revisited

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PDE4阻害薬（ジファミラスト軟膏）;Nihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunology;2023-12-20

2. Non‐Type 2 and Mixed Inflammation in Chronic Rhinosinusitis and Lower Airway Disease;The Laryngoscope;2023-08-24

3. Regenerative and translational medicine in COPD: hype and hope;European Respiratory Review;2023-07-26

4. Biologic drugs in the treatment of chronic inflammatory pulmonary diseases: recent developments and future perspectives;Frontiers in Immunology;2023-06-02

5. Advances in the development of phosphodiesterase-4 inhibitors;European Journal of Medicinal Chemistry;2023-03